Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Deal Watch: Millendo Completes Merger With OvaScience, With $85m In Bank For Two Mid-Stage Programs

Executive Summary

OvaScience’s cash plus a $49.5m venture capital raise leave Millendo with more than enough to get two current programs to data readouts in early 2020, company says. AMAG merges with Perosphere, adding to its hematology business.


Related Content

Biogen By Buying Nightstar Targets Ophthalmology As Emerging Growth Area
Nine Catalysts For China Biopharma In 2019
Lilly And AC Immune Partner On A Small Molecule With Potential In Alzheimer's Combinations
Flush With Fresh Funds, ReViral CEO Outlines RSV Trial Plans
IP Commercializer PureTech's CEO Outlines 2018 Roadmap After Financing
Microbiome Clinical Studies Loom Large In 2018
Millendo Gets European Foothold With Alizé Acquisition
AGTC scores with Biogen deal in gene therapy
Vedanta strikes deal with Janssen for IBD therapy


Related Companies

Related Deals




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts